Phytopharm plc Stock London S.E.
Equities
GB0006869720
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
Sales 2024 * | 5.2M 6.49M | Sales 2025 * | - | Capitalization | 4.17M 5.21M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.5M | Net income 2025 * | - | EV / Sales 2024 * | 0.53 x |
Net cash position 2024 * | 1.4M 1.75M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.57
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.5% |
Latest transcript on Phytopharm plc
Managers | Title | Age | Since |
---|---|---|---|
Giulio Cerroni
CEO | Chief Executive Officer | 63 | 17-02-05 |
Director of Finance/CFO | 47 | 19-05-30 | |
Charles Spicer
CHM | Chairman | 59 | 13-10-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 13-10-13 |
Director/Board Member | 48 | 16-09-15 | |
Dipti Amin
BRD | Director/Board Member | 60 | 23-10-04 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |